ProFunds Biotechnology UltraSector Fund Investor Class BIPIX:NASDAQ

Net Asset Value$52.43Previous Close - 5/17/2019
1-Day Change-0.37(0.70%)
YTD Change+0.52(1.00%)

Growth of $10,000 Since Fund Inception

View portfolioPortfolio as of 01/31/2019

Top 5 SectorsTop 5 Holdings
Health Technology69.84%
AbbVie Inc ORD10.38%
Health Services2.03%
Amgen Inc ORD10.24%
Commercial Services1.04%
Gilead Sciences Inc ORD7.78%
  
Biogen Inc ORD5.78%
  
Celgene Corp ORD5.31%
Concentration of Top 572.91% Concentration of Top 539.49% 

Fund Profile

Fund Strategy

The Fund seeks daily investment results, before fees and expenses, that correspond to 150% of the performance of the Dow Jones U.S. Biotechnology Index.

Fund Category Sector Equity
Inception Date 06/19/2000
Manager Neches/Dave
Fund Classification Equity Leverage Funds
Managed Since 2013
Other Managed Funds   UYG  ROM  INPIX  BIB  WCPIX

Lipper Leader Scorecard as of 04/30/2019

RatingTotal
Return
Consistent
Return
PreservationTax
Efficiency
Expense*
Overall Rating(# of funds in category)
188

185

12,251

188

43
3 Year Rating(# of funds in category)
188

186

12,251

188

43
5 Year Rating(# of funds in category)
159

157

10,368

159

40
10 Year Rating(# of funds in category)
115

115

6,994

115

39

Fund Highlights

Total Expense Ratio1.43%
Average Market Capitallization$64.4 B
Net Asset ValueN/A
Total Net Assets$183.9 M
Sales ExpensesNo Load Fund
Minimum Initial Investment$15000
Minimum IRA Investment$15000
AvailabilityOpen to New Investors
Current Yield0.00%
Dividend Ex-DateN/A

Risk Analysis

Beta vs. S&P 5002.13
R-Squared vs. S&P 5000.57
Standard Deviation30.07%
Sharpe Ratio0.41
Portfolio TurnoverN/A